Orange Book

Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.

Orange Book

(security, standard)
A standard from the US Government National Computer Security Council (an arm of the U.S. National Security Agency), "Trusted Computer System Evaluation Criteria, DOD standard 5200.28-STD, December 1985" which defines criteria for trusted computer products. There are four levels, A, B, C, and D. Each level adds more features and requirements.

D is a non-secure system.

C1 requires user log-on, but allows group ID.

C2 requires individual log-on with password and an audit mechanism. (Most Unix implementations are roughly C1, and can be upgraded to about C2 without excessive pain).

Levels B and A provide mandatory control. Access is based on standard Department of Defense clearances.

B1 requires DOD clearance levels.

B2 guarantees the path between the user and the security system and provides assurances that the system can be tested and clearances cannot be downgraded.

B3 requires that the system is characterised by a mathematical model that must be viable.

A1 requires a system characterized by a mathematical model that can be proven.

See also crayola books, book titles.
References in periodicals archive ?
After a blockbuster success for Droom's Orange Book Value (OBV), which provides a fair market value of any used vehicle, Droom has launched OBV for Mobile, a pricing engine for used mobile phones.
This Orange Book listing requirement eases the administrative burden on the FDA, because the agency need not review patents outside the Orange Book.
Mr German urged the party's leadership to listen to grassroots supporters rather than those in a "rarefied policy atmosphere" who developed the Orange Book agenda.
On September 11, 2007 Cubist had asked the FDA to de-list the pharmaceutical composition patent from the Orange Book so that it could seek a technical correction.
The Orange Book has created a great furore in the press.
Some actions, he pointed out, have been taken in response to settlements between brand-name companies and generics applicants, improper listings in the Food and Drug Administration's so-called Orange Book, settlements between generics manufacturers an alleged abuse of the government regulatory process.
The patent has composition of matter claims covering the MOVIPREP purgative that will be listed in the Orange Book.
The three newly issued patents will be listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (Orange-Book) bringing Eagle's total Orange Book listed patents for Bendeka to thirteen.
In conjunction, three of the company's newly issued patents will be listed in the US FDA's Approved Drug Products with Therapeutic Equivalents Evaluations (Orange-Book) bringing the total Orange Book listed patents for Bendeka to nine.
Food and Drug Administration (FDA) publication, Approved Drug Products with Therapeutic Equivalence Evaluations, commonly known as the Orange Book, patent number 9468747.
Both the IMPAX and Anchen ANDAs for generic Wellbutrin 300 mg were filed with Paragraph IV certifications with respect to certain patents held by Biovail Laboratories International SRL and listed in the Orange Book.